• Published On : Jan-2018 |
  • Pages : 216 Pages |
  • Format :

Table of Content

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Taxonomy
     2.2. Market Definition

3. Rheumatoid Arthritis Diagnosis Tests Market Opportunity Analysis 
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis
     3.3. Pricing Analysis, by Region
            3.3.1. Product Pricing Analysis
            3.3.2. Service Pricing Analysis

4. North America Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
     4.1. Introduction
     4.2. Regional Market Dynamics
            4.2.1. Drivers
            4.2.2. Restraints
            4.2.3. Trends
     4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            4.3.1. U.S.
            4.3.2. Canada
     4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
            4.4.1. U.S.
            4.4.2. Canada
     4.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
            4.5.1. Serology Test Type
                     4.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     4.5.1.2. Rheumatoid Factor (RF) Test Type
                     4.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     4.5.1.4. Antinuclear Antibody (ANA) Test Type
                     4.5.1.5. Uric Acid Test Type
                     4.5.1.6. Other Test Type
            4.5.2. Monitoring RA Treatment Efficiency Tests
                     4.5.2.1. Salicylate Level Count Test Type
                     4.5.2.2. Muscle Enzyme Tests Type
                     4.5.2.3. Creatinine Test Type
     4.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
            4.6.1. Serology Test Type
                     4.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     4.6.1.2. Rheumatoid Factor (RF) Test Type
                     4.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     4.6.1.4. Antinuclear Antibody (ANA) Test Type
                     4.6.1.5. Uric Acid Test Type
                     4.6.1.6. Other Test Type
            4.6.2. Monitoring RA Treatment Efficiency Tests
                     4.6.2.1. Salicylate Level Count Test Type
                     4.6.2.2. Muscle Enzyme Tests Type
                     4.6.2.3. Creatinine Test Type
     4.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
            4.7.1. Diagnostics laboratories
                     4.7.1.1. Public Laboratories
                     4.7.1.2. Private Laboratories
            4.7.2. Ambulatory Surgical Centers
            4.7.3. Hospitals 
     4.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
            4.8.1. Diagnostics laboratories
                     4.8.1.1. Public Laboratories
                     4.8.1.2. Private Laboratories
            4.8.2. Ambulatory Surgical Centers
            4.8.3. Hospitals 
     4.9. Drivers and Restraints: Impact Analysis
     4.10. Market Attractiveness Analysis
            4.10.1. By Country
            4.10.2. By Test Type
            4.10.3. By End User
     4.11. Key Representative Market Participants
     4.12. Market Presence (Intensity Map)

5. Latin America Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
     5.1. Introduction
     5.2. Regional Market Dynamics
            5.2.1. Drivers
            5.2.2. Restraints
            5.2.3. Trends
     5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            5.3.1. Brazil
            5.3.2. Mexico
            5.3.3. Rest of Latin America
     5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
            5.4.1. Brazil
            5.4.2. Mexico
            5.4.3. Rest of Latin America
     5.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
            5.5.1. Serology Test Type
                     5.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     5.5.1.2. Rheumatoid Factor (RF) Test Type
                     5.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     5.5.1.4. Antinuclear Antibody (ANA) Test Type
                     5.5.1.5. Uric Acid Test Type
                     5.5.1.6. Other Test Type
            5.5.2. Monitoring RA Treatment Efficiency Tests
                     5.5.2.1. Salicylate Level Count Test Type
                     5.5.2.2. Muscle Enzyme Tests Type
                     5.5.2.3. Creatinine Test Type
     5.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
            5.6.1. Serology Test Type
                     5.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     5.6.1.2. Rheumatoid Factor (RF) Test Type
                     5.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     5.6.1.4. Antinuclear Antibody (ANA) Test Type
                     5.6.1.5. Uric Acid Test Type
                     5.6.1.6. Other Test Type
            5.6.2. Monitoring RA Treatment Efficiency Tests
                     5.6.2.1. Salicylate Level Count Test Type
                     5.6.2.2. Muscle Enzyme Tests Type
                     5.6.2.3. Creatinine Test Type
     5.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
            5.7.1. Diagnostics laboratories
                     5.7.1.1. Public Laboratories
                     5.7.1.2. Private Laboratories
            5.7.2. Ambulatory Surgical Centers
            5.7.3. Hospitals
     5.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
            5.8.1. Diagnostics laboratories
                     5.8.1.1. Public Laboratories
                     5.8.1.2. Private Laboratories
            5.8.2. Ambulatory Surgical Centers
            5.8.3. Hospitals
     5.9. Drivers and Restraints: Impact Analysis
     5.10. Market Attractiveness Analysis
            5.10.1. By Country
            5.10.2. By Test Type
            5.10.3. By End User
     5.11. Key Representative Market Participants
     5.12. Market Presence (Intensity Map)

6. Europe Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
     6.1. Introduction
     6.2. Regional Market Dynamics
            6.2.1. Drivers
            6.2.2. Restraints
            6.2.3. Trends
     6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            6.3.1. Germany
            6.3.2. U.K.
            6.3.3. France
            6.3.4. Italy
            6.3.5. Spain
            6.3.6. Russia
            6.3.7. Rest of Europe
     6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
            6.4.1. Germany
            6.4.2. U.K.
            6.4.3. France
            6.4.4. Italy
            6.4.5. Spain
            6.4.6. Russia
            6.4.7. Rest of Europe
     6.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
            6.5.1. Serology Test Type
                     6.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     6.5.1.2. Rheumatoid Factor (RF) Test Type
                     6.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     6.5.1.4. Antinuclear Antibody (ANA) Test Type
                     6.5.1.5. Uric Acid Test Type
                     6.5.1.6. Other Test Type
            6.5.2. Monitoring RA Treatment Efficiency Tests
                     6.5.2.1. Salicylate Level Count Test Type
                     6.5.2.2. Muscle Enzyme Tests Type
                     6.5.2.3. Creatinine Test Type
     6.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
            6.6.1. Serology Test Type
                     6.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     6.6.1.2. Rheumatoid Factor (RF) Test Type
                     6.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     6.6.1.4. Antinuclear Antibody (ANA) Test Type
                     6.6.1.5. Uric Acid Test Type
                     6.6.1.6. Other Test Type
            6.6.2. RA Treatment Efficiency Tests
                     6.6.2.1. Salicylate Level Count Test Type
                     6.6.2.2. Muscle Enzyme Tests Type
                     6.6.2.3. Creatinine Test Type
     6.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
            6.7.1. Diagnostics laboratories
                     6.7.1.1. Public Laboratories
                     6.7.1.2. Private Laboratories
            6.7.2. Ambulatory Surgical Centers
            6.7.3. Hospitals 
     6.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
            6.8.1. Diagnostics laboratories
                     6.8.1.1. Public Laboratories
                     6.8.1.2. Private Laboratories
            6.8.2. Ambulatory Surgical Centers
            6.8.3. Hospitals 
     6.9. Drivers and Restraints: Impact Analysis
     6.10. Market Attractiveness Analysis
            6.10.1. By Country
            6.10.2. By Test Type
            6.10.3. By End User
     6.11. Key Representative Market Participants
     6.12. Market Presence (Intensity Map)

7. Asia Pacific Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
     7.1. Introduction
     7.2. Regional Market Dynamics
            7.2.1. Drivers
            7.2.2. Restraints
            7.2.3. Trends
     7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            7.3.1. China
            7.3.2. Japan
            7.3.3. India
            7.3.4. ASEAN
            7.3.5. Australia and New Zealand
            7.3.6. Rest of Asia Pacific
     7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
            7.4.1. China
            7.4.2. Japan
            7.4.3. India
            7.4.4. ASEAN
            7.4.5. Australia and New Zealand
            7.4.6. Rest of Asia Pacific
     7.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
            7.5.1. Serology Test Type
                     7.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     7.5.1.2. Rheumatoid Factor (RF) Test Type
                     7.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     7.5.1.4. Antinuclear Antibody (ANA) Test Type
                     7.5.1.5. Uric Acid Test Type
                     7.5.1.6. Other Test Type
            7.5.2. Monitoring RA Treatment Efficiency Tests
                     7.5.2.1. Salicylate Level Count Test Type
                     7.5.2.2. Muscle Enzyme Tests Type
                     7.5.2.3. Creatinine Test Type
     7.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
            7.6.1. Serology Test Type
                     7.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     7.6.1.2. Rheumatoid Factor (RF) Test Type
                     7.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     7.6.1.4. Antinuclear Antibody (ANA) Test Type
                     7.6.1.5. Uric Acid Test Type
                     7.6.1.6. Other Test Type
            7.6.2. Monitoring RA Treatment Efficiency Tests
                     7.6.2.1. Salicylate Level Count Test Type
                     7.6.2.2. Muscle Enzyme Tests Type
                     7.6.2.3. Creatinine Test Type
     7.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
            7.7.1. Hospitals 
            7.7.2. Diagnostics laboratories
                     7.7.2.1. Public Laboratories
                     7.7.2.2. Private Laboratories
            7.7.3. Ambulatory Surgical Centers
     7.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
            7.8.1. Hospitals 
            7.8.2. Diagnostics laboratories
                     7.8.2.1. Public Laboratories
                     7.8.2.2. Private Laboratories
            7.8.3. Ambulatory Surgical Centers
     7.9. Drivers and Restraints: Impact Analysis
     7.10. Market Attractiveness Analysis
            7.10.1. By Country
            7.10.2. By Test Type
            7.10.3. By End User
     7.11. Key Representative Market Participants
     7.12. Market Presence (Intensity Map)

8. Middle East & Africa Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
     8.1. Introduction
     8.2. Regional Market Dynamics
            8.2.1. Drivers
            8.2.2. Restraints
            8.2.3. Trends
     8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
            8.3.1. GCC Countries
            8.3.2. South Africa
            8.3.3. North Africa
            8.3.4. Rest of MEA
     8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
            8.4.1. GCC Countries
            8.4.2. South Africa
            8.4.3. North Africa
            8.4.4. Rest of MEA
     8.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
            8.5.1. Serology Test Type
                     8.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     8.5.1.2. Rheumatoid Factor (RF) Test Type
                     8.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     8.5.1.4. Antinuclear Antibody (ANA) Test Type
                     8.5.1.5. Uric Acid Test Type
                     8.5.1.6. Other Test Type
            8.5.2. Monitoring RA Treatment Efficiency Tests
                     8.5.2.1. Salicylate Level Count Test Type
                     8.5.2.2. Muscle Enzyme Tests Type
                     8.5.2.3. Creatinine Test Type
     8.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
            8.6.1. Serology Test Type
                     8.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     8.6.1.2. Rheumatoid Factor (RF) Test Type
                     8.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     8.6.1.4. Antinuclear Antibody (ANA) Test Type
                     8.6.1.5. Uric Acid Test Type
                     8.6.1.6. Other Test Type
            8.6.2. Monitoring RA Treatment Efficiency Tests
                     8.6.2.1. Salicylate Level Count Test Type
                     8.6.2.2. Muscle Enzyme Tests Type
                     8.6.2.3. Creatinine Test Type
     8.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
            8.7.1. Diagnostics laboratories
                     8.7.1.1. Public Laboratories
                     8.7.1.2. Private Laboratories
            8.7.2. Ambulatory Surgical Centers
            8.7.3. Hospitals 
     8.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
            8.8.1. Diagnostics laboratories
                     8.8.1.1. Public Laboratories
                     8.8.1.2. Private Laboratories
            8.8.2. Ambulatory Surgical Centers
            8.8.3. Hospitals 
     8.9. Drivers and Restraints: Impact Analysis
     8.10. Market Attractiveness Analysis
            8.10.1. By Country
            8.10.2. By Test Type
            8.10.3. By End User
     8.11. Key Representative Market Participants
     8.12. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
     11.1. Market Structure
     11.2. Competition Intensity Mapping by Market Taxonomy
     11.3. Competition Dashboard
     11.4. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
            11.4.1. Abbott Laboratories, Inc.
            11.4.2. Antibodies Inc.
            11.4.3. Beckman Coulter, Inc.
            11.4.4. Euro Diagnostica AB
            11.4.5. F. Hoffmann-La Roche Ltd.
            11.4.6. Qiagen N.V.
            11.4.7. Siemens Healthcare GmbH
            11.4.8. Thermo Fisher Scientific, Inc.
            11.4.9. Bio Rad Laboratories Inc.
            11.4.10. Genway Biotech, Inc. (Aviva Systems Biology Corp.)

12. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Region
     12.1. Introduction/Key Findings
     12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
            12.2.1. North America
            12.2.2. Latin America
            12.2.3. Europe
            12.2.4. Asia Pacific
            12.2.5. Middle East & Africa
     12.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
            12.3.1. North America
            12.3.2. Latin America
            12.3.3. Europe
            12.3.4. Asia Pacific
            12.3.5. Middle East & Africa
     12.4. Market Attractiveness Analysis By Region

13. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Test Type
     13.1. Introduction/Key Findings
     13.2. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
            13.2.1. Serology Test Type
                     13.2.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     13.2.1.2. Rheumatoid Factor (RF) Test Type
                     13.2.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     13.2.1.4. Antinuclear Antibody (ANA) Test Type
                     13.2.1.5. Uric Acid Test Type
                     13.2.1.6. Other Test Type
            13.2.2. Monitoring RA Treatment Efficiency Tests
                     13.2.2.1. Salicylate Level Count Test Type
                     13.2.2.2. Muscle Enzyme Tests Type
                     13.2.2.3. Creatinine Test Type
     13.3. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
            13.3.1. Serology Test Type
                     13.3.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
                     13.3.1.2. Rheumatoid Factor (RF) Test Type
                     13.3.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
                     13.3.1.4. Antinuclear Antibody (ANA) Test Type
                     13.3.1.5. Uric Acid Test Type
                     13.3.1.6. Other Test Type
            13.3.2. Monitoring RA Treatment Efficiency Tests
                     13.3.2.1. Salicylate Level Count Test Type
                     13.3.2.2. Muscle Enzyme Tests Type
                     13.3.2.3. Creatinine Test Type
     13.4. Drivers and Restraints: Impact Analysis
     13.5. Market Attractiveness Analysis By Technology

14. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027, By End Users
     14.1. Introduction/Key Findings
     14.2. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
            14.2.1. Diagnostics laboratories
                     14.2.1.1. Public Laboratories
                     14.2.1.2. Private Laboratories
            14.2.2. Ambulatory Surgical Centers
            14.2.3. Hospitals 
     14.3. Market Size (US$ Mn) Forecast By End Users, 2017–2027
            14.3.1. Diagnostics laboratories
                     14.3.1.1. Public Laboratories
                     14.3.1.2. Private Laboratories
            14.3.2. Ambulatory Surgical Centers
            14.3.3. Hospitals 
     14.4. Drivers and Restraints: Impact Analysis
     14.5. Market Attractiveness Analysis By Products

15. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
     15.1. Market Size and Y-o-Y Growth
     15.2. Absolute $ Opportunity
     15.3. Value Chain

16. Research Methodology


List of Tables

Table 01: Global Rheumatoid Arthritis Diagnosis Test Market Pricing Analysis (US$) by Region, 2016
Table 02: North America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 03: North America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 04: North America Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 05: North America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 06: Latin America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 07: Latin America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 08: Latin America Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 09: Latin America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 10: Europe Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 11: Europe Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 12: Europe Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 13: Europe Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 14: APAC Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 15: APAC Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 16: APAC Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 17: APAC Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 18: MEA Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 19: MEA Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 20: MEA Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 21: MEA Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 22: Global Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) 2012–2016 and Forecast 2017-2027 By Region
Table 23: Global Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Test Type
Table 24: Global Rheumatoid Arthritis Diagnosis Test Market Volume (Mn Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 25: Global Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) 2012–2016 and Forecast 2017-2027 By End User


List of Figures

Figure 01: Rheumatoid Arthritis Diagnosis Test Market Revenue Share by Product Type 2017E & 2027F
Figure 02: Rheumatoid Arthritis Diagnosis Test Market Revenue Share by End User, 2017E & 2027F
Figure 03: Rheumatoid Arthritis Diagnosis Test Market Revenue Share by Region, 2017E & 2027F
Figure 05: Rheumatoid Arthritis Diagnosis Test Market, Price (US$)Difference (U.S Vs. Japan), 2016
Figure 06: Global Rheumatoid Arthritis Diagnosis Test Market Serology Tests, Price Difference (US$) By Region, 2016A
Figure 07: Global Rheumatoid Arthritis Diagnosis Test Market Serology Tests, Price Difference (US$) By Region, 2027
Figure 08: Global Rheumatoid Arthritis Diagnosis Test Market Monitoring RA Treatment Efficiency Tests, Price Difference (US$) By Region, 2016A
Figure 09: Global Rheumatoid Arthritis Diagnosis Test Market Monitoring RA Treatment Efficiency Tests, Price Difference (US$) By Region, 2027
Figure 10: North America Rheumatoid Arthritis Diagnosis Test Market Value Share (2017E)
Figure 11: North America Rheumatoid Arthritis Diagnosis Test Market Value Share Analysis (%) By Country, 2017 & 2027
Figure 12: North America Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 13: North America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 14: U.S. Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 15: U.S. Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 16: Canada Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 17: Canada Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 18: North America Serology Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 19: North America Serology Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 20: North America Monitoring RA Treatment Efficiency Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 21: North America Monitoring RA Treatment Efficiency Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 22: North America Diagnostic Laboratories Market Size (US$ Mn) Analysis, 2012–2016
Figure 23: North America Diagnostic Laboratories Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 24: North America Ambulatory Surgical Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 25: North America Ambulatory Surgical Centers Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 26: North America Hospitals Market Size (US$ Mn) Analysis, 2012–2016
Figure 27: North America Hospitals Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 28: North America Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Test Type, 2017–2027
Figure 29: North America Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By End User, 2017–2027
Figure 30: North America Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Country, 2017–2027
Figure 31: Latin America Rheumatoid Arthritis Diagnosis Test Market Value Share (2017E)
Figure 32: Latin America Rheumatoid Arthritis Diagnosis Test Market Value Share Analysis (%) By Country, 2017 & 2027
Figure 33: Latin America Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 34: Latin America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 35: Argentina Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 36: Argentina Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 37: Brazil Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 38: Brazil Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 39: Mexico Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 40: Mexico Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 41: Rest of Latin America Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 42: Rest of Latin America Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 43: Latin America Serology Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 44: Latin America Serology Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 45: Latin America Monitoring RA Treatment Efficiency Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 46: Latin America Monitoring RA Treatment Efficiency Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 47: Latin America Diagnostic Laboratories Market Size (US$ Mn) Analysis, 2012–2016
Figure 48: Latin America Diagnostic Laboratories Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 49: Latin America Ambulatory Surgical Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 50: Latin America Ambulatory Surgical Centers Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 51: Latin America Hospitals Market Size (US$ Mn) Analysis, 2012–2016
Figure 52: Latin America Hospitals Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 53: Latin America Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Test Type, 2017–2027
Figure 54: Latin America Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By End User, 2017–2027
Figure 55: Latin America Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Country, 2017–2027
Figure 56: Europe Rheumatoid Arthritis Diagnosis Test Market Value Share (2017E)
Figure 57: Europe Rheumatoid Arthritis Diagnosis Test Market Value Share Analysis (%) By Country, 2017 & 2027
Figure 58: Europe Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 59: Europe Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 60: Germany Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 61: Germany Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 62: France Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 63: France Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 64: Spain Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 65: Spain Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 66: Italy Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 67: Italy Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 68: U.K. Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 69: U.K. Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 70: Russia Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 71: Russia Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 72: Poland Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 73: Poland Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 74: Rest of Europe Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 75: Rest of Europe Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 76: Europe Serology Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 77: Europe Serology Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 78: Europe Monitoring RA Treatment Efficiency Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 79: Europe Monitoring RA Treatment Efficiency Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 80: Europe Diagnostic Laboratories Market Size (US$ Mn) Analysis, 2012–2016
Figure 81: Europe Diagnostic Laboratories Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 82: Europe Ambulatory Surgical Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 83: Europe Ambulatory Surgical Centers Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 84: Europe Hospitals Market Size (US$ Mn) Analysis, 2012–2016
Figure 85: Europe Hospitals Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 86: Europe Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Test Type, 2017–2027
Figure 87: Europe Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By End User, 2017–2027
Figure 88: Europe Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Country, 2017–2027
Figure 89: APAC Rheumatoid Arthritis Diagnosis Test Market Value Share (2017E)
Figure 90: APAC Rheumatoid Arthritis Diagnosis Test Market Value Share Analysis (%) By Country, 2017 & 2027
Figure 91: APAC Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 92: APAC Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 93: China Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 94: China Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 95: India Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 96: India Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 97: Japan Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 98: Japan Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 99: Australia & New Zealand Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 100: Australia & New Zealand Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%),2017–2027
Figure 101: Rest of APAC Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 102: Rest of APAC Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 103: APAC Serology Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 104: APAC Serology Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 105: APAC Monitoring RA Treatment Efficiency Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 106: APAC Monitoring RA Treatment Efficiency Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 107: APAC Diagnostic Laboratories Market Size (US$ Mn) Analysis, 2012–2016
Figure 108: APAC Diagnostic Laboratories Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 109: APAC Ambulatory Surgical Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 110: APAC Ambulatory Surgical Centers Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 111: APAC Hospitals Market Size (US$ Mn) Analysis, 2012–2016
Figure 112: APAC Hospitals Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 113: APAC Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Test Type, 2017–2027
Figure 114: APAC Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By End User, 2017–2027
Figure 115: APAC Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Country, 2017–2027
Figure 116: MEA Rheumatoid Arthritis Diagnosis Test Market Value Share (2017E)
Figure 117: MEA Rheumatoid Arthritis Diagnosis Test Market Value Share Analysis (%) By Country, 2017 & 2027
Figure 118: MEA Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 119: MEA Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 120: GCC countries Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 121: GCC countries Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 122: South Africa Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 123: South Africa Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 124: Rest of MEA Rheumatoid Arthritis Diagnosis Test Historical Market Size (US$ Mn) Analysis, 2012–2016
Figure 125: Rest of MEA Rheumatoid Arthritis Diagnosis Test Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 126: MEA Serology Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 127: MEA Serology Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 128: MEA Monitoring RA Treatment Efficiency Tests Market Size (US$ Mn) Analysis, 2012–2016
Figure 129: MEA Monitoring RA Treatment Efficiency Tests Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 130: MEA Diagnostic Laboratories Market Size (US$ Mn) Analysis, 2012–2016
Figure 131: MEA Diagnostic Laboratories Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 132: MEA Ambulatory Surgical Centers Market Size (US$ Mn) Analysis, 2012–2016
Figure 133: MEA Ambulatory Surgical Centers Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 134: MEA Hospitals Market Size (US$ Mn) Analysis, 2012–2016
Figure 135: MEA Hospitals Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2027
Figure 136: MEA Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Test Type, 2017–2027
Figure 137: MEA Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By End User, 2017–2027
Figure 138: MEA Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Country, 2017–2027
Figure 139: Global Rheumatoid Arthritis Diagnosis Test Market Share Analysis (%) By Region, 2017 & 2027
Figure 140: Global Rheumatoid Arthritis Diagnosis Test Market Y-o-Y Growth (%) By Region, 2017–2027
Figure 141: Global Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Region, 2017–2027
Figure 142: Global Rheumatoid Arthritis Diagnosis Test Market Share Analysis (%) By Test Type, 2017 & 2027
Figure 143: Global Rheumatoid Arthritis Diagnosis Test Market Y-o-Y Growth (%) By Test Type, 2017–2027
Figure 144: Global Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By Test Type, 2017–2027
Figure 145: Global Rheumatoid Arthritis Diagnosis Test Market Share Analysis (%) By End User, 2017 & 2027
Figure 146: Global Rheumatoid Arthritis Diagnosis Test Market Y-o-Y Growth (%) By End User, 2017–2027
Figure 147: Global Rheumatoid Arthritis Diagnosis Test Market Attractiveness Analysis By End User, 2017–2027
Figure 148: Global Rheumatoid Arthritis Diagnosis Test Market Value Analysis and Forecast, 2016–2027 (US$ Mn)
Figure 149: Global Rheumatoid Arthritis Diagnosis Test Market Absolute $ Opportunity (US$ Mn), 2016–2025